Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Oguchi disease is an autosomal recessive retinal disorder characterized by congenital stationary night blindness and the Mizuo-Nakamura phenomenon.
Biomarker and diagnostic research for Oguchi disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
19 publications have been identified in PubMed for Oguchi disease. Research spans Case Report / Case Series (53%), Basic Science / Preclinical (16%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 53% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:15 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Oguchi disease
Laboratory research |
3 |
16% |
Research summaries | 2 | 11% |
Testing and diagnosis research | 1 | 5% |
Clinical study results | 1 | 5% |
Disease patterns and progression | 1 | 5% |
New treatment approaches | 1 | 5% |
Mariscal J (2026). [PMID: 41110996](https://pubmed.ncbi.nlm.nih.gov/41110996/). *Ophthalmic Genet*. [Case Report / Case Series]
Fathy N (2026). [PMID: 41520369](https://pubmed.ncbi.nlm.nih.gov/41520369/). *Ophthalmic Genet*. [Gene Therapy / Novel Therapeutics]
Rana V (2026). [PMID: 41772076](https://pubmed.ncbi.nlm.nih.gov/41772076/). *Eye (Lond)*. [Case Report / Case Series]
Molina Martín JC (2026). [PMID: 42039976](https://pubmed.ncbi.nlm.nih.gov/42039976/). *Int J Ophthalmol*. [Basic Science / Preclinical]
Nakata K (2026). [PMID: 42144321](https://pubmed.ncbi.nlm.nih.gov/42144321/). *Intern Med*. [Case Report / Case Series]
Tekin K (2026). [PMID: 42162247](https://pubmed.ncbi.nlm.nih.gov/42162247/). *Eye (Lond)*. [Case Report / Case Series]
Suzuki T (2026). [PMID: 42223036](https://pubmed.ncbi.nlm.nih.gov/42223036/). *Allergy Asthma Immunol Res*. [Clinical Trial Publication]
Miyo K (2025). [PMID: 40806623](https://pubmed.ncbi.nlm.nih.gov/40806623/). *Int J Mol Sci*. [Basic Science / Preclinical]
Salom D (2025). [PMID: 39704710](https://pubmed.ncbi.nlm.nih.gov/39704710/). *Biochemistry*. [Basic Science / Preclinical]
Pawar N (2025). [PMID: 41102555](https://pubmed.ncbi.nlm.nih.gov/41102555/). *Eye (Lond)*. [Case Report / Case Series]